Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted The Role of HGF c Met Pathway Signaling in Human Medulloblastoma IntechOpen Molecular mechanism(s) of regulation(s) of c MET HGF signaling in head and neck cancer Molecular Cancer Springer Nature Link Dihexa is an experimental cognitive peptide that may help the brain build stronger connections between neurons instead of just temporarily boosting neurotransmitters like many nootropics do. It works through the HGF c Met pathway, Frontiers HGF and MET: From Brain Development to Neurological Disorders